| Vladimir C Adloff, MD | |
|
1026 A Ave Ne, Cedar Rapids, IA 52402-5036 | |
| (319) 369-7002 | |
| (319) 369-8095 |
| Full Name | Vladimir C Adloff |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1026 A Ave Ne, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841266103 | NPI | - | NPPES |
| 0277111 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 34667 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vladimir C Adloff, MD 1026 A Ave Ne, Cedar Rapids, IA 52402-5036 Ph: (319) 369-7002 | Vladimir C Adloff, MD 1026 A Ave Ne, Cedar Rapids, IA 52402-5036 Ph: (319) 369-7002 |
News Archive
Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with chronic, high-risk, NYHA class II or III heart failure with reduced ejection fraction (HFrEF), especially among those who have higher levels of inflammation, yet hospitalization was not reduced, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Employers plan to further reward workers for healthy behavior such as quitting smoking or losing weight with lower insurance premiums or cash prizes, the Los Angeles Times reports.
Identifying the genetic malfunction that causes these disorders raises the hope that researchers may be able to devise a targeted therapy, just as they have done for chronic myelogenous leukemia (CML), which is presently treated with Gleevec. The three leukemias that share a common genetic cause are polycythemia vera (PV), essential thrombocythemia (ET) and myeloid metaplasia with myelofibrosis (MMM).
A surgical patient safety program that combines three components-accurate outcome measurement, support of hospital leadership, and engaged frontline providers-reduces surgical site infections (SSIs) by 33 percent in patients who undergo colorectal procedures, according to a new study published in the August issue of the Journal of the American College of Surgeons.
› Verified 5 days ago
Dr. Dale L. Waldner, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7002 | |
Dr. Julie Carol Netser, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1911 1st Ave Se, Cedar Rapids, IA 52402 Phone: 319-366-1503 Fax: 319-366-6976 | |
Keith D Krewer, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7002 Fax: 319-369-8095 | |
Dr. Richard Frederick Fiester, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5531 Hickorywood Ct, Cedar Rapids, IA 52411 Phone: 319-395-9535 Fax: 319-395-9284 | |
Dr. Thomas J Bollinger, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7002 Fax: 319-369-8095 | |
Dorryl L Buck Jr., MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7002 Fax: 319-369-8095 | |
Ruth A Macke, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1026 A Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-7002 Fax: 319-369-8095 |